Dark Streaming/Mobile Old Site Home Products Help Contact Us Your Account System Status
Sign-up for a FREE 30-day Stockwatch subscription and SEE NO ADS
01:29:58 EDT Tue 30 Apr 2024
Enter Symbol
or Name
USA
CA



Q:ENTA - ENANTA PHARMACEUTICALS INC - Website unknown - click to update
Sym-XBid - AskLastChg%ChVol$Vol#TrOpen-Hi-LoYear Hi-LoLast TrNewsDelay
ENTA - Q0.111.71·14.510.113.25+0.887.1245.43,1821,22512.35  13.34  12.3537.75  8.0817:12:3707:0015 min RT 2¢

Recent Trades - Last 10 of 1225
Time ETExPriceChangeVolume
17:12:37Q13.250.8832,550
16:54:04Q13.250.8888,255
16:06:05Q13.250.883,933
16:02:08Q13.250.88535
16:00:39Q13.300.931,276
16:00:05Q13.250.8836,500
16:00:04Q13.250.88121
16:00:04Q13.250.8842
16:00:01Q13.250.8869
16:00:01Q13.250.88200

Sign-up for a FREE 30-day Stockwatch subscription and SEE NO ADS

Recent Bulletins
Date ETSymbolTypeHeadline
2024-04-29 07:00U:ENTANews ReleaseEnanta Pharmaceuticals to Host Conference Call on May 6 at 4:30 p.m. ET to Discuss its Financial Results for its Fiscal Second Quarter Ended March 31, 2024
2024-04-17 07:00U:ENTANews ReleaseEnanta Pharmaceuticals Announces Data Presentation at ESCMID Global 2024
2024-03-06 07:00U:ENTANews ReleaseEnanta Pharmaceuticals to Participate at Leerink Partners Global Biopharma Conference
2024-02-07 16:01U:ENTANews ReleaseEnanta Pharmaceuticals Reports Financial Results for its Fiscal First Quarter Ended December 31, 2023 with Webcast and Conference Call Today at 4:30 p.m. ET
2024-02-06 07:00U:ENTANews ReleaseEnanta Pharmaceuticals to Participate at the Oppenheimer 34th Annual Healthcare Life Sciences Conference
2024-01-31 07:00U:ENTANews ReleaseEnanta Pharmaceuticals to Host Conference Call on February 7 at 4:30 p.m. ET to Discuss its Financial Results for its Fiscal First Quarter Ended December 31, 2023
2024-01-04 07:00U:ENTANews ReleaseEnanta Pharmaceuticals to Provide Updates on its Research and Development Programs and 2024 Outlook at the 42nd Annual J.P. Morgan Healthcare Conference
2024-01-03 07:00U:ENTANews ReleaseEnanta Pharmaceuticals to Present at the 42nd Annual J.P. Morgan Healthcare Conference
2023-11-22 07:00U:ENTANews ReleaseEnanta Pharmaceuticals to Participate at Evercore ISI HealthCONx Conference
2023-11-20 16:01U:ENTANews ReleaseEnanta Pharmaceuticals Reports Financial Results for its Fiscal Fourth Quarter and Year Ended September 30, 2023, with Webcast and Conference Call Today at 4:30 p.m. ET
2023-11-13 07:00U:ENTANews ReleaseEnanta Pharmaceuticals to Host Conference Call on November 20 at 4:30 p.m. ET to Discuss its Financial Results for its Fiscal Fourth Quarter and Full Year Ended September 30, 2023
2023-10-13 07:00U:ENTANews ReleaseEnanta Pharmaceuticals to Host Virtual Key Opinion Leader Event to Discuss Advances in the Treatment Landscape for Respiratory Syncytial Virus (RSV) and its Proprietary RSV Pipeline
2023-09-17 12:00U:ENTANews ReleaseEnanta Pharmaceuticals to Present Data for EDP-323, its Oral, Once-Daily, L-Protein Inhibitor in Development for the Treatment of Respiratory Syncytial Virus, at the 9th ESWI Influenza Conference
2023-09-07 07:00U:ENTANews ReleaseEnanta Pharmaceuticals to Present Data for EDP-938, its Oral, Once-Daily, N-Protein Inhibitor in Development for the Treatment of Respiratory Syncytial Virus, at IDWeek ¢ „ ¢ 2023
2023-08-31 07:00U:ENTANews ReleaseEnanta Pharmaceuticals to Participate in Investor Conferences in September
2023-08-07 16:01U:ENTANews ReleaseEnanta Pharmaceuticals Reports Financial Results for its Fiscal Third Quarter with Conference Call and Webcast Today at 4:30 p.m. ET
2023-07-31 07:00U:ENTANews ReleaseEnanta Pharmaceuticals to Host Conference Call on August 7 at 4:30 p.m. ET to Discuss its Financial Results for Its Fiscal Third Quarter Ended June 30, 2023
2023-06-20 07:00U:ENTANews ReleaseEnanta Pharmaceuticals Announces Positive Data From a Phase 1 Clinical Study of EDP-323, an Oral, L-Protein Inhibitor in Development for the Treatment of Respiratory Syncytial Virus
2023-06-07 07:00U:ENTANews ReleaseEnanta Pharmaceuticals Announces Data Presentation at the European Association for the Study of the Liver (EASL) International Liver Congress ¢ „ ¢ 2023
2023-05-31 07:00U:ENTANews ReleaseEnanta Pharmaceuticals to Participate at Jefferies Global Healthcare Conference